Yale Pathology uses AI platform for prostate cancer diagnoses; Artera enrolls first DIRECT-AI registry patient

Aug 14, 2026 · Issue 2 · 3 sources, 3 articles

Yale Pathology is using an AI platform to support prostate cancer diagnoses. Artera has enrolled the first patient in its DIRECT-AI registry, which collects real-world data on AI-powered prostate cancer care (August 14).

Who is affected and how

doctor

Pathologists and oncologists can follow real-world data on AI-supported prostate diagnostics.

medtech company

The registry is an example of real-world evidence generation for AI-based products.

Sources

• Yale Pathology Using AI Platform to Support Prostate Cancer Diagnoses | Yale School of Medicinemedicine.yale.edu · Aug 14, 2026
• Yale Pathology Using AI Platform to Support Prostate Cancer Diagnosesyale school of medicine · Aug 14, 2026
• Artera Enrolls First Patient in DIRECT-AI Registry, Marking Milestone in Real-World Evidence Generation for AI-Powered Prostate Cancer Care - BioSpacebiospace.com · Aug 14, 2026 · magyar

Machine-generated summary based on the titles and excerpts of the source articles. The source article is the authority for the facts. News monitoring, not medical advice: consult a doctor for health decisions.